Pair Name | Nimbolide, Docetaxel | ||
Phytochemical Name | Nimbolide (PubChem CID: 12313376 ) | ||
Anticancer drug Name | Docetaxel (PubChem CID: 148124 ) | ||
Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
Pair Name | Nimbolide, Docetaxel | |||
Disease Info | [ICD-11: 2C82] | Prostate cancer | Investigative | |
Biological Phenomena | Induction-->Apoptosis | |||
Gene Regulation | Down-regulation | Expression | BCL2 | hsa596 |
Down-regulation | Activity | NFKB1 | hsa4790 | |
Down-regulation | Expression | XIAP | hsa331 | |
In Vitro Model | LNCaP | Prostate carcinoma | Homo sapiens (Human) | CVCL_0395 |
PC-3 | Prostate carcinoma | Homo sapiens (Human) | CVCL_0035 | |
PC-3 D12 | Prostate carcinoma | Homo sapiens (Human) | CVCL_4Y40 | |
In Vivo Model | 8-week-old male SCID mice were orthotopically implanted with LNCaP-Luc or PC-3-Luc cells to induce tumors. | |||
Result | The combination of NL and DTX significantly reduced the DNA binding ability of NF-κB in both cell types. NL significantly enhanced the antitumor effect of DTX and reduced metastases in orthotopic models of prostate cancer. NL abolishes DTX-induced-NF-κB activation to counteract cell proliferation, tumor growth, and metastasis in the prostate cancer models. |
No. | Title | Href |
---|---|---|
1 | Nimbolide enhances the antitumor effect of docetaxel via abrogation of the NF-κB signaling pathway in prostate cancer preclinical models. Biochim Biophys Acta Mol Cell Res. 2022 Dec;1869(12):119344. doi: 10.1016/j.bbamcr.2022.119344. | Click |